Literature DB >> 11161951

Effects of asynchronous ventricular activation on myocardial adrenergic innervation in patients with permanent dual-chamber pacemakers; an I(123)-metaiodobenzylguanidine cardiac scintigraphic study.

E N Simantirakis1, V K Prassopoulos, S I Chrysostomakis, G E Kochiadakis, S I Koukouraki, J P Lekakis, N S Karkavitsas, P E Vardas.   

Abstract

AIMS: To evaluate myocardial sympathetic innervation abnormalities in patients with DDD pacemakers for complete heart block.
METHODS: We studied 39 patients, chronically paced in DDD mode because of complete atrioventricular block. Twenty-three healthy individuals served as a control group. All patients underwent planar and single-photon emission computed tomography (SPECT) myocardial imaging 4 h after intravenous infusion of 185 MBq I(123)-MIBG. The heart to mediastinum ratio was calculated to quantify cardiac I(123)-MIBG accumulation, while the SPECT study was performed to investigate the regional distribution of adrenergic innervation. All patients underwent a SPECT thallium(201)myocardial study during the same week as the I(123)-MIBG study.
RESULTS: The heart to mediastinum ratio was significantly smaller in paced patients than in the controls (P<0.001). 89.7% of paced patients had regional abnormalities of I(123)-MIBG uptake, mainly in the inferior (92.3%) and apical (38.5%) wall. 46.2% of paced patients had regional perfusion defects, also mainly in the inferior (46.2%) and apical (10.3%) wall. Neither the I(123)-MIBG abnormalities nor the perfusion defects were related to the duration of pacing.
CONCLUSIONS: Stimulation from the apex of the right ventricle leads to regional disturbances of the adrenergic innervation of the left ventricular myocardium, as assessed by I(123)-MIBG activity. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161951     DOI: 10.1053/euhj.2000.2482

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  7 in total

1.  Neuronal damage and abnormal contraction: Is the circle of synchronicity complete?

Authors:  Claudio Marcassa
Journal:  J Nucl Cardiol       Date:  2018-01-11       Impact factor: 5.952

2.  123I-MIBG imaging detects cardiac involvement and predicts cardiac events in Churg-Strauss syndrome.

Authors:  Yoriko Horiguchi; Yukiko Morita; Naomi Tsurikisawa; Kazuo Akiyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-23       Impact factor: 9.236

3.  Prognostic value of sympathetic innervation and cardiac asynchrony in dilated cardiomyopathy.

Authors:  Alain Manrique; Mathieu Bernard; Anne Hitzel; Fabrice Bauer; Jean-François Ménard; Rémi Sabatier; Arnold Jacobson; Pierre Véra; Denis Agostini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-06       Impact factor: 9.236

4.  Assessment of myocardial adrenergic innervation in patients with sick sinus syndrome: effect of asynchronous ventricular activation from ventricular apical stimulation.

Authors:  M E Marketou; E N Simantirakis; V K Prassopoulos; S I Chrysostomakis; A A Velidaki; N S Karkavitsas; P E Vardas
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

5.  Analysis of Dyssynchrony and Ventricular Function in Right Univentricular Stimulation at Different Positions.

Authors:  Ana Paula Susin Osório; Stefan Warpechowski; Antonio Lessa Gaudie Ley; Marcelo Haertel Miglioranza; Laura Lessa Gaudie Ley; Eduardo Dytz Almeida; Roberto Tofani Sant'anna; Tiago Luiz Luz Leiria
Journal:  Braz J Cardiovasc Surg       Date:  2017 Nov-Dec

6.  Turkish Society of Cardiology consensus paper on management of arrhythmia-induced cardiomyopathy.

Authors:  Taner Ulus; Kaan Okyay; Hasan Kutsi Kabul; Emin Evren Özcan; Özcan Özeke; Hakan Altay; Bülent Görenek; Aylin Yıldırır; Sercan Okutucu; Abdullah Tekin
Journal:  Anatol J Cardiol       Date:  2019-02       Impact factor: 1.596

7.  Arrhythmia induced cardiomyopathy.

Authors:  Hariharan Sugumar; Sandeep Prabhu; Aleksandr Voskoboinik; Peter M Kistler
Journal:  J Arrhythm       Date:  2018-07-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.